Renal Cancer - Results from #8540

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: Basis of new prognostic scoring systems - Abstract March 16, 2012

Pazopanib: An orally administered multi-targeted tyrosine kinase inhibitor for locally advanced or metastatic renal cell carcinoma - Abstract March 15, 2012

New insights into molecular mechanisms of sunitinib-associated side effects - Abstract March 14, 2012

Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: Correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging - Abstract March 13, 2012

Papillary thyroid carcinoma-like tumor of the kidney: A case report - Abstract March 12, 2012

Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma - Abstract March 9, 2012

Thrombocytosis and hematocrit as prognostic factors in renal carcinoma - Abstract March 8, 2012

Comparison of open and minimally invasive partial nephrectomy for renal tumors 4-7 centimeters - Abstract March 6, 2012

Consolidative surgery after targeted therapy for renal cell carcinoma - Abstract March 5, 2012

Evaluation of treatment response in patients with metastatic renal cell carcinoma: Role of state-of-the-art cross-sectional imaging - Abstract February 27, 2012

Cessation of vascular endothelial growth factor-targeted therapy in patients with metastatic renal cell carcinoma: Feasibility and clinical outcome - Abstract February 22, 2012

Metachronous pancreatic metastases from renal cell carcinoma: Role of imaging in a review of 17 cases with surgical correlation - Abstract February 15, 2012

TroVax(®) vaccine therapy for renal cell carcinoma - Abstract February 15, 2012

T lymphocyte recruitment into renal cell carcinoma tissue: a role for chemokine receptors CXCR3, CXCR6, CCR5, and CCR6 - Abstract February 13, 2012

Vascular disruption in combination with mTOR inhibition in renal cell carcinoma - Abstract February 10, 2012

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses - Abstract February 10, 2012

Pancreatic metastases from renal cell carcinoma: The state of the art - Abstract February 10, 2012

Targeted therapies in metastatic renal cell carcinoma: Overview of the past year - Abstract February 9, 2012

Interferon-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ - Abstract February 8, 2012

Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: A retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients - Abstract February 8, 2012

Page 428 of 455